Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site
mi
from
Portland, OR
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site
mi
from
Portland, OR
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site 012
mi
from
Johnstown, PA
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site 012
mi
from
Johnstown, PA
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site 094
mi
from
Sioux Falls, SD
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site 094
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site 13
mi
from
Nashville, TN
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site 13
mi
from
Nashville, TN
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site
mi
from
Houston, TX
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site 045
mi
from
The Woodlands, TX
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site 045
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site 019
mi
from
Ogden, UT
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site 019
mi
from
Ogden, UT
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative site 100
mi
from
Salt Lake City, UT
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative site 100
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site 023
mi
from
Roanoke, VA
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site 023
mi
from
Roanoke, VA
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site #027
mi
from
Seattle, WA
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site #027
mi
from
Seattle, WA
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site 049
mi
from
Milwaukee, WI
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site 049
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site 204
mi
from
Brussel,
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site 204
mi
from
Brussel,
Click here to add this to my saved trials
Response Inhibition Training for Individuals With Trichotillomania
Testing the Feasibility of Response Inhibition Enhancement Training for Individuals With Trichotillomania
Status: Enrolling
Updated:  11/1/2013
The Psychology Clinic, University of Wisconsin-Milwaukee
mi
from
Milwaukee, WI
Response Inhibition Training for Individuals With Trichotillomania
Testing the Feasibility of Response Inhibition Enhancement Training for Individuals With Trichotillomania
Status: Enrolling
Updated: 11/1/2013
The Psychology Clinic, University of Wisconsin-Milwaukee
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Pioglitazone for Heroin and for Nicotine Dependence
Effects of Pioglitazone, a PPARγ Agonist, on the Abuse Liability of Heroin and of Nicotine
Status: Enrolling
Updated:  11/4/2013
New York State Psychiatric Institute
mi
from
New York, NY
Pioglitazone for Heroin and for Nicotine Dependence
Effects of Pioglitazone, a PPARγ Agonist, on the Abuse Liability of Heroin and of Nicotine
Status: Enrolling
Updated: 11/4/2013
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Eating Disorders in Type 1 Diabetes: Mechanisms of Comorbidity
Eating Disorders in Type 1 Diabetes: Mechanisms of Comorbidity
Status: Enrolling
Updated:  11/4/2013
Duke University Health System
mi
from
Durham, NC
Eating Disorders in Type 1 Diabetes: Mechanisms of Comorbidity
Eating Disorders in Type 1 Diabetes: Mechanisms of Comorbidity
Status: Enrolling
Updated: 11/4/2013
Duke University Health System
mi
from
Durham, NC
Click here to add this to my saved trials
Effect of Lower Back Treatment in People With Patellofemoral Pain Syndrome.
Effect of Lumbopelvic Manipulation on Hip and Knee Neuromuscular Activity, Pain Intensity, and Functional Activity in People With Patellofemoral Pain Syndrome.
Status: Enrolling
Updated:  11/5/2013
Texas Woman's University, School of Physical Therapy - Dallas Campus
mi
from
Dallas, TX
Effect of Lower Back Treatment in People With Patellofemoral Pain Syndrome.
Effect of Lumbopelvic Manipulation on Hip and Knee Neuromuscular Activity, Pain Intensity, and Functional Activity in People With Patellofemoral Pain Syndrome.
Status: Enrolling
Updated: 11/5/2013
Texas Woman's University, School of Physical Therapy - Dallas Campus
mi
from
Dallas, TX
Click here to add this to my saved trials
Developmental Origins of Attention Deficit Hyperactivity Disorder
Developmental Origins of Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated:  11/6/2013
Oregon Health and Science University
mi
from
Portland, OR
Developmental Origins of Attention Deficit Hyperactivity Disorder
Developmental Origins of Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 11/6/2013
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression
Adjunctive Lisdexamfetamine in Bipolar Depression
Status: Enrolling
Updated:  11/13/2013
Lindner Center of HOPE
mi
from
Mason, OH
Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression
Adjunctive Lisdexamfetamine in Bipolar Depression
Status: Enrolling
Updated: 11/13/2013
Lindner Center of HOPE
mi
from
Mason, OH
Click here to add this to my saved trials
A Pilot Trial of Citicoline in Individuals With Mild Traumatic Brain Injury (mTBI)
A Pilot Trial of Citicoline in Individuals With mTBI
Status: Enrolling
Updated:  11/13/2013
McLean Hospital, Brain Imaging Center
mi
from
Belmont, MA
A Pilot Trial of Citicoline in Individuals With Mild Traumatic Brain Injury (mTBI)
A Pilot Trial of Citicoline in Individuals With mTBI
Status: Enrolling
Updated: 11/13/2013
McLean Hospital, Brain Imaging Center
mi
from
Belmont, MA
Click here to add this to my saved trials
Effects of TAK-063 on Preventing Ketamine-Induced Brain Activity Changes as Well as Psychotic-Like Symptoms in Healthy Male Adults
A Randomized, Investigator and Subject-Blind, Placebo-Controlled, Single-Dose, 3-Period, Incomplete Block Cross-Over Study to Evaluate the Effects of Single Oral Administration of TAK-063 on Preventing Ketamine-Induced Brain Activity Changes as Well as Psychotic-Like Symptoms in Healthy Male Adults
Status: Enrolling
Updated:  11/18/2013
The Brain Institute of the University of Utah
mi
from
Salt Lake City, UT
Effects of TAK-063 on Preventing Ketamine-Induced Brain Activity Changes as Well as Psychotic-Like Symptoms in Healthy Male Adults
A Randomized, Investigator and Subject-Blind, Placebo-Controlled, Single-Dose, 3-Period, Incomplete Block Cross-Over Study to Evaluate the Effects of Single Oral Administration of TAK-063 on Preventing Ketamine-Induced Brain Activity Changes as Well as Psychotic-Like Symptoms in Healthy Male Adults
Status: Enrolling
Updated: 11/18/2013
The Brain Institute of the University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
PTSD Symptom Reduction by Propranolol Given After Trauma Memory Activation
PTSD Symptom Reduction by Propranolol Given After Memory Activation
Status: Enrolling
Updated:  11/19/2013
VA Medical Center Manchester
mi
from
Manchester, NH
PTSD Symptom Reduction by Propranolol Given After Trauma Memory Activation
PTSD Symptom Reduction by Propranolol Given After Memory Activation
Status: Enrolling
Updated: 11/19/2013
VA Medical Center Manchester
mi
from
Manchester, NH
Click here to add this to my saved trials
Study of Chiropractic and Neuromuscular Reeducation as a Treatment for Autism Symptoms
The Effects of Spinal Manipulative Therapy and Neuromuscular Reeducation on the Presentation of Autistic Symptoms in Children
Status: Enrolling
Updated:  11/21/2013
Southern California University of Health Sciences
mi
from
Whittier, CA
Study of Chiropractic and Neuromuscular Reeducation as a Treatment for Autism Symptoms
The Effects of Spinal Manipulative Therapy and Neuromuscular Reeducation on the Presentation of Autistic Symptoms in Children
Status: Enrolling
Updated: 11/21/2013
Southern California University of Health Sciences
mi
from
Whittier, CA
Click here to add this to my saved trials
Study of PTSD in Military Veterans Who Have Suffered Traumatic Brain Injuries
A Randomized Prospective Clinical Trial of PTSD in Military Veterans Who Have Suffered Traumatic Brain Injuries
Status: Enrolling
Updated:  12/2/2013
Carrick Brain Centers
mi
from
Irving, TX
Study of PTSD in Military Veterans Who Have Suffered Traumatic Brain Injuries
A Randomized Prospective Clinical Trial of PTSD in Military Veterans Who Have Suffered Traumatic Brain Injuries
Status: Enrolling
Updated: 12/2/2013
Carrick Brain Centers
mi
from
Irving, TX
Click here to add this to my saved trials
Executive Dysfunction and Suicide in Psychiatric Outpatients and Inpatients
Executive Dysfunction and Suicide in Psychiatric Outpatients and Inpatients
Status: Enrolling
Updated:  12/4/2013
VA Eastern Colorado Health Care System, Denver
mi
from
Denver, CO
Executive Dysfunction and Suicide in Psychiatric Outpatients and Inpatients
Executive Dysfunction and Suicide in Psychiatric Outpatients and Inpatients
Status: Enrolling
Updated: 12/4/2013
VA Eastern Colorado Health Care System, Denver
mi
from
Denver, CO
Click here to add this to my saved trials
A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment
Atomoxetine Treatment for Opioid Maintained Cocaine Users
Status: Enrolling
Updated:  12/12/2013
Department of Veterans Affairs Hospital
mi
from
West Haven, CT
A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment
Atomoxetine Treatment for Opioid Maintained Cocaine Users
Status: Enrolling
Updated: 12/12/2013
Department of Veterans Affairs Hospital
mi
from
West Haven, CT
Click here to add this to my saved trials
Transcranial Magnetic Stimulation (TMS) and Obsessive Compulsive Disorder (OCD)
Treatment of Obsessive Compulsive Disorder (OCD) With Transcranial Magnetic Stimulation (TMS)
Status: Enrolling
Updated:  12/16/2013
New York State Psychiatric Institute, Experimental Therapeutics
mi
from
New York, NY
Transcranial Magnetic Stimulation (TMS) and Obsessive Compulsive Disorder (OCD)
Treatment of Obsessive Compulsive Disorder (OCD) With Transcranial Magnetic Stimulation (TMS)
Status: Enrolling
Updated: 12/16/2013
New York State Psychiatric Institute, Experimental Therapeutics
mi
from
New York, NY
Click here to add this to my saved trials
Using Heart Rate Variability Biofeedback to Improve Attention and Memory in PTSD+ Combat Veterans
Using Heart Rate Variability Biofeedback to Improve Attention and Memory in PTSD+ Combat Veterans
Status: Enrolling
Updated:  12/17/2013
Dorn VA Medical Center
mi
from
Columbia, SC
Using Heart Rate Variability Biofeedback to Improve Attention and Memory in PTSD+ Combat Veterans
Using Heart Rate Variability Biofeedback to Improve Attention and Memory in PTSD+ Combat Veterans
Status: Enrolling
Updated: 12/17/2013
Dorn VA Medical Center
mi
from
Columbia, SC
Click here to add this to my saved trials
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated:  12/17/2013
Johns Hopkins University
mi
from
Baltimore, MD
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated: 12/17/2013
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated:  12/17/2013
University of Maryland
mi
from
Baltimore, MD
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated: 12/17/2013
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated:  12/17/2013
The Zucker Hillside Hospital
mi
from
Glen Oaks, NY
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated: 12/17/2013
The Zucker Hillside Hospital
mi
from
Glen Oaks, NY
Click here to add this to my saved trials
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated:  12/17/2013
Univ of North Carolina
mi
from
Chapel Hill, NC
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated: 12/17/2013
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
Glendale, AL
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
Glendale, AL
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
Homewood, AL
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
Homewood, AL
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
Mobile, AL
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
Mobile, AL
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
Phoenix, AZ
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
Glendora, CA
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
Glendora, CA
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
Murrieta, CA
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
Murrieta, CA
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
San Diego, CA
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
San Diego, CA
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
San Diego, CA
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
San Diego, CA
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
Farmington, CT
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
Farmington, CT
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
New Britain, CT
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
New Britain, CT
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
Boynton Beach, FL
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
Plantation, FL
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
Plantation, FL
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
Coeur D'alene, ID
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
Coeur D'alene, ID
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
Idaho Falls, ID
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
Meridian, ID
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
Meridian, ID
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
Shreveport, LA
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
Shreveport, LA
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
Annapolis, MD
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
Annapolis, MD
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
Ann Arbor, MI
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
mi
from
Grand Rapids, MI
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
mi
from
Grand Rapids, MI
Click here to add this to my saved trials